ArticleDysphagia2026
Efficacy of Neuromuscular Electrical Stimulation Combined with Traditional Swallowing Therapy in Acute Stroke Patients with Dysphagia: A Randomized Controlled Trial.
Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Neuromuscular electrical stimulation (NMES) has been proposed as an adjunct to conventional swallowing therapy; however, evidence regarding its additive benefit in early-stage stroke remains inconclusive. This study aimed to determine whether NMES combined with traditional swallowing therapy provides superior outcomes compared with traditional therapy alone in enteral tube-dependent patients with acute and subacute post-stroke dysphagia. A total of 57 participants with post-stroke dysphagia who met the inclusion criteria were randomly assigned to either the NMES combined with traditional swallowing therapy group or the traditional swallowing therapy with sham stimulation group. Both groups were scheduled to receive 10 treatment sessions over a 2-week period. Outcomes were assessed at baseline, after the first week of the intervention, at the end of the 2-week intervention period, and 2 weeks after completion of the intervention. The primary outcome was functional oral intake measured by the Functional Oral Intake Scale (FOIS). Secondary outcomes included swallowing-related symptom severity (EAT-10) and swallowing-related quality of life (SWAL-QOL). Both groups demonstrated significant improvement over time. However, the NMES group showed significantly greater improvements in FOIS after the first week of the intervention, at the end of the 2-week intervention period, and 2 weeks after completion of the intervention (all p < 0.05). Greater reductions in EAT-10 scores were also observed in the NMES group across all post-intervention assessments. Improvements in SWAL-QOL total scores were significant in both groups, with a between-group difference observed only after the first week of the intervention. Adjunctive NMES enhances early functional recovery and symptom reduction in acute and subacute post-stroke dysphagia.
Indexed as
Identifiers
42634036What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.